FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

James Dale

Research Profile

Living Beings

Chemicals & Drugs

Disorders

Streptococcal Infections

Physiology

Co-author Network

Publications

TOP 3
James B Dale; Vincent A Fischetti; Jonathan R Carapetis; Joachim Maria Hombach; Rajesh Kumar; Bongani M Mayosi; Kim Mulholland; Fran A Rubin; Florian Schödel; Samba O Sow; Andrew C Steer; Ana-Maria Henao-Restrepo
Group A streptococcal vaccines: paving a path for accelerated development.
James B Dale; James P Nataro; Thomas A Penfound; Samba O Sow; Boubou Tamboura; Milagritos D Tapia; Karen L Kotloff
Potential coverage of a multivalent M protein-based group A streptococcal vaccine.
James B Dale; Thomas A Penfound; Edna Y Chiang; William J Walton
New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococci.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of James Dale (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: James B Dale; Vincent A Fischetti; Jonathan R Carapetis; Joachim Maria Hombach; Rajesh Kumar; Bongani M Mayosi; Kim Mulholland; Fran A Rubin; Florian Schödel; Samba O Sow; Andrew C Steer; Ana-Maria Henao-Restrepo
Group A streptococcal vaccines: paving a path for accelerated development.
Vaccine 2013;31 Suppl 2():B216-22.
2013: James B Dale; James P Nataro; Thomas A Penfound; Samba O Sow; Boubou Tamboura; Milagritos D Tapia; Karen L Kotloff
Potential coverage of a multivalent M protein-based group A streptococcal vaccine.
Vaccine 2013;31(12):1576-81.
2011: James B Dale; Thomas A Penfound; Edna Y Chiang; William J Walton
New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococci.
Vaccine 2011;29(46):8175-8.
2010: Michael S Bronze; James B Dale
Progress in the development of effective vaccines to prevent selected gram-positive bacterial infections.
The American journal of the medical sciences 2010;340(3):218-25.
2010: Thomas A Penfound; Edna Y Chiang; Elwaleed A Ahmed; James B Dale
Protective efficacy of group A streptococcal vaccines containing type-specific and conserved M protein epitopes.
Vaccine 2010;28(31):5017-22.
2010: Thomas A Penfound; Itzhak Ofek; Harry S Courtney; David L Hasty; James B Dale
The NH(2)-terminal region of Streptococcus pyogenes M5 protein confers protection against degradation by proteases and enhances mucosal colonization of mice.
The Journal of infectious diseases 2010;201(10):1580-8.
2009: Stanford T Shulman; Tanz Rachid; James B Dale; Bernard W. Beall; William Kabat; Kathleen Kabat; Emily Cederlund; Devendra Patel; Jason Rippe; Zhongya Li; Varja Sakota
Seven-year surveillance of north american pediatric group a streptococcal pharyngitis isolates.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009;49(1):78-84.
2009: Kathleen H Cox; Eduardo Ruiz-Bustos; Harry S Courtney; James B Dale; Morgan A Pence; Victor Nizet; Ramy Aziz; Ivan C Gerling; Susan M Price; David L Hasty
Inactivation of DltA modulates virulence factor expression in Streptococcus pyogenes.
PloS one 2009;4(4):e5366.
2009: Harry S Courtney; Itzhak Ofek; Thomas Penfound; Victor Nizet; Morgan A Pence; Bernd Kreikemeyer; Andreas Podbielski; Andreas Podbielbski; David L Hasty; James B Dale
Relationship between expression of the family of M proteins and lipoteichoic acid to hydrophobicity and biofilm formation in Streptococcus pyogenes.
PloS one 2009;4(1):e4166.
2008: James B Dale
Current status of group A streptococcal vaccine development.
Advances in experimental medicine and biology 2008;609():53-63.
2006: Stanford T Shulman; Gene Stollerman; Bernard W. Beall; James B Dale; Tanz Rachid
Temporal changes in streptococcal M protein types and the near-disappearance of acute rheumatic fever in the United States.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;42(4):441-7.
2006: Harry S Courtney; David L Hasty; James B Dale
Anti-phagocytic mechanisms of Streptococcus pyogenes: binding of fibrinogen to M-related protein.
Molecular microbiology 2006;59(3):936-47.
2005: Shelly A McNeil; Scott A Halperin; Joanne M Langley; Bruce Smith; Andrew Warren; Geoffrey P Sharratt; Darlene M Baxendale; Mark A Reddish; Mary C Hu; Steven D Stroop; Janine Linden; Louis Fries; Peter E Vink; James B Dale
Safety and immunogenicity of 26-valent group a streptococcus vaccine in healthy adult volunteers.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;41(8):1114-22.
2005: James B Dale; Thomas Penfound; Edna Y Chiang; Valerie Long; Stanford T Shulman; Bernard W. Beall
Multivalent group A streptococcal vaccine elicits bactericidal antibodies against variant M subtypes.
Clinical and diagnostic laboratory immunology 2005;12(7):833-6.
2004: Karen L Kotloff; Mary C Corretti; Kathleen Palmer; James D Campbell; Mark A Reddish; Mary C Hu; Steven Wasserman; James B Dale
Safety and immunogenicity of a recombinant multivalent group a streptococcal vaccine in healthy adults: phase 1 trial.
JAMA : the journal of the American Medical Association 2004;292(6):709-15.
2004: Stanford T Shulman; Tanz Rachid; William Kabat; Kathleen Kabat; Emily Cederlund; Devendra Patel; Zhongya Li; Varja Sakota; James B Dale; Bernard W. Beall
Group A streptococcal pharyngitis serotype surveillance in North America, 2000-2002.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;39(3):325-32.
2004: Karen L Kotloff; James B Dale
Progress in group A streptococcal vaccine development.
The Pediatric infectious disease journal 2004;23(8):765-6.
2004: Mary A Hall; Steven D Stroop; Mary C Hu; Michael A Walls; Mark A Reddish; David S Burt; George H Lowell; James B Dale
Intranasal immunization with multivalent group A streptococcal vaccines protects mice against intranasal challenge infections.
Infection and immunity 2004;72(5):2507-12.
2003: Harry S Courtney; David L Hasty; James B Dale
Serum opacity factor (SOF) of Streptococcus pyogenes evokes antibodies that opsonize homologous and heterologous SOF-positive serotypes of group A streptococci.
Infection and immunity 2003;71(9):5097-103.
2002: Harry S Courtney; James B Dale; David L Hasty
Mapping the fibrinogen-binding domain of serum opacity factor of group a streptococci.
Current microbiology 2002;44(4):236-40.
2002: Mary C Hu; Michael A Walls; Steven D Stroop; Mark A Reddish; Bernard W. Beall; James B Dale
Immunogenicity of a 26-valent group A streptococcal vaccine.
Infection and immunity 2002;70(4):2171-7.
2002: James B Dale; Edna Y Chiang; David L Hasty; Harry S Courtney
Antibodies against a synthetic peptide of SagA neutralize the cytolytic activity of streptolysin S from group A streptococci.
Infection and immunity 2002;70(4):2166-70.
2002: Harry S Courtney; David L Hasty; James B Dale
Molecular mechanisms of adhesion, colonization, and invasion of group A streptococci.
Annals of medicine 2002;34(2):77-87.
2001: D G McLellan; Edna Y Chiang; Harry S Courtney; David L Hasty; S C Wei; Mary C Hu; Michael A Walls; J J Bloom; James B Dale
Spa contributes to the virulence of type 18 group A streptococci.
Infection and immunity 2001;69(5):2943-9.
1999: James B Dale; Edna Y Chiang; S Liu; Harry S Courtney; David L Hasty
New protective antigen of group A streptococci.
The Journal of clinical investigation 1999;103(9):1261-8.
1999: Harry S Courtney; David L Hasty; Y Li; H C Chiang; J L Thacker; James B Dale
Serum opacity factor is a major fibronectin-binding protein and a virulence determinant of M type 2 Streptococcus pyogenes.
Molecular microbiology 1999;32(1):89-98.
1999: James B Dale
Group A streptococcal vaccines.
Infectious disease clinics of North America 1999;13(1):227-43, viii.
1999: James B Dale
Multivalent group A streptococcal vaccine designed to optimize the immunogenicity of six tandem M protein fragments.
Vaccine 1999;17(2):193-200.
1998: James B Dale
Group A streptococcal vaccines.
Pediatric annals 1998;27(5):301-8.
1997: S I Hasan; E Whitnack; James B Dale
Fusobacterial cerebritis and myelitis presenting as acute paraplegia in an elderly man with congenital heart disease.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1997;25(3):741-2.
1997: Harry S Courtney; S Liu; James B Dale; David L Hasty
Conversion of M serotype 24 of Streptococcus pyogenes to M serotypes 5 and 18: effect on resistance to phagocytosis and adhesion to host cells.
Infection and immunity 1997;65(6):2472-4.
1997: S Liu; Harry S Courtney; D E Bessen; David L Hasty; James B Dale
M protein expression is not required for resistance to phagocytosis of type 18 group A streptococci.
Advances in experimental medicine and biology 1997;418():725-7.
1997: Harry S Courtney; James B Dale; David L Hasty
Host cell specific adhesins of group A streptococci.
Advances in experimental medicine and biology 1997;418():605-6.
1996: James B Dale; M Simmons; E C Chiang; E Y Chiang
Recombinant, octavalent group A streptococcal M protein vaccine.
Vaccine 1996;14(10):944-8.
1996: Harry S Courtney; James B Dale; D I Hasty
Differential effects of the streptococcal fibronectin-binding protein, FBP54, on adhesion of group A streptococci to human buccal cells and HEp-2 tissue culture cells.
Infection and immunity 1996;64(7):2415-9.
1996: Michael S Bronze; James B Dale
The reemergence of serious group A streptococcal infections and acute rheumatic fever.
The American journal of the medical sciences 1996;311(1):41-54.
1995: James B Dale; E C Chiang
Intranasal immunization with recombinant group A streptococcal M protein fragment fused to the B subunit of Escherichia coli labile toxin protects mice against systemic challenge infections.
The Journal of infectious diseases 1995;171(4):1038-41.
1994: Harry S Courtney; Michael S Bronze; James B Dale; David L Hasty
Analysis of the role of M24 protein in group A streptococcal adhesion and colonization by use of omega-interposon mutagenesis.
Infection and immunity 1994;62(11):4868-73.
1994: Harry S Courtney; Y Li; James B Dale; David L Hasty
Cloning, sequencing, and expression of a fibronectin/fibrinogen-binding protein from group A streptococci.
Infection and immunity 1994;62(9):3937-46.
1994: James B Dale; rob baird; Harry S Courtney; David L Hasty; Michael S Bronze
Passive protection of mice against group A streptococcal pharyngeal infection by lipoteichoic acid.
The Journal of infectious diseases 1994;169(2):319-23.
1993: Michael S Bronze; James B Dale
Epitopes of streptococcal M proteins that evoke antibodies that cross-react with human brain.
Journal of immunology (Baltimore, Md. : 1950) 1993;151(5):2820-8.
1993: James B Dale; E Y Chiang; J W Lederer
Recombinant tetravalent group A streptococcal M protein vaccine.
Journal of immunology (Baltimore, Md. : 1950) 1993;151(4):2188-94.
1992: Harry S Courtney; David L Hasty; James B Dale; T P Poirier
A 28-kilodalton fibronectin-binding protein of group A streptococci.
Current microbiology 1992;25(5):245-50.
1992: Harry S Courtney; C von Hunolstein; James B Dale; Michael S Bronze; E H Beachey; David L Hasty
Lipoteichoic acid and M protein: dual adhesins of group A streptococci.
Microbial pathogenesis 1992;12(3):199-208.
1992: Michael S Bronze; Harry S Courtney; James B Dale
Epitopes of group A streptococcal M protein that evoke cross-protective local immune responses.
Journal of immunology (Baltimore, Md. : 1950) 1992;148(3):888-93.
1991: rob baird; Michael S Bronze; W Kraus; H R Hill; L G Veasey; James B Dale
Epitopes of group A streptococcal M protein shared with antigens of articular cartilage and synovium.
Journal of immunology (Baltimore, Md. : 1950) 1991;146(9):3132-7.
1990: W Kraus; James B Dale; E H Beachey
Identification of an epitope of type 1 streptococcal M protein that is shared with a 43-kDa protein of human myocardium and renal glomeruli.
Journal of immunology (Baltimore, Md. : 1950) 1990;145(12):4089-93.
1990: James B Dale; Harry S Courtney; Malak Kotb; D Schifferli
Phosphorylase-cross-reactive antibodies evoked by streptococcal M protein.
Infection and immunity 1990;58(3):774-8.
1989: Malak Kotb; Harry S Courtney; James B Dale; E H Beachey
Cellular and biochemical responses of human T lymphocytes stimulated with streptococcal M proteins.
Journal of immunology (Baltimore, Md. : 1950) 1989;142(3):966-70.
1988: Michael S Bronze; David McKinsey; E H Beachey; James B Dale
Protective immunity evoked by locally administered group A streptococcal vaccines in mice.
Journal of immunology (Baltimore, Md. : 1950) 1988;141(8):2767-70.
1988: Michael S Bronze; E H Beachey; James B Dale
Protective and heart-crossreactive epitopes located within the NH2 terminus of type 19 streptococcal M protein.
The Journal of experimental medicine 1988;167(6):1849-59.
1988: E H Beachey; Michael S Bronze; James B Dale; W Kraus; T Poirier; S Sargent
Protective and autoimmune epitopes of streptococcal M proteins.
Vaccine 1988;6(2):192-6.
1988: Michael S Bronze; David McKinsey; E H Beachey; James B Dale
Pathogenesis of group A streptococci in mice and efficacy of locally administered streptococcal vaccines.
Transactions of the Association of American Physicians 1988;101():88-92.
1987: James B Dale; E H Beachey
Human cytotoxic T lymphocytes evoked by group A streptococcal M proteins.
The Journal of experimental medicine 1987;166(6):1825-35.
1987: W Kraus; E Haanes-Fritz; P P Cleary; J M Seyer; James B Dale; E H Beachey
Sequence and type-specific immunogenicity of the amino-terminal region of type 1 streptococcal M protein.
Journal of immunology (Baltimore, Md. : 1950) 1987;139(9):3084-90.
1987: Michael S Bronze; E H Beachey; J M Seyer; James B Dale
Protective and heart-cross-reactive epitopes of type 19 streptococcal M protein.
Transactions of the Association of American Physicians 1987;100():80-4.
1985: C L Ganguly; James B Dale; Harry S Courtney; E H Beachey
Tyrosine phosphorylation of a 94-kDa protein of human fibroblasts stimulated by streptococcal lipoteichoic acid.
The Journal of biological chemistry 1985;260(24):13342-6.
1985: T P Poirier; Michael A Kehoe; James B Dale; K N Timmis; E H Beachey
Expression of protective and cardiac tissue cross-reactive epitopes of type 5 streptococcal M protein in Escherichia coli.
Infection and immunity 1985;48(1):198-203.
1984: E Whitnack; James B Dale; E H Beachey
Common protective antigens of group A streptococcal M proteins masked by fibrinogen.
The Journal of experimental medicine 1984;159(4):1201-12.
1983: E H Beachey; J M Seyer; James B Dale; David L Hasty
Repeating covalent structure and protective immunogenicity of native and synthetic polypeptide fragments of type 24 streptococcal M protein. Mapping of protective and nonprotective epitopes with monoclonal antibodies.
The Journal of biological chemistry 1983;258(21):13250-7.
1983: E H Beachey; W Andrew Simpson; Itzhak Ofek; David L Hasty; James B Dale; E Whitnack
Attachment of Streptococcus pyogenes to mammalian cells.
Reviews of infectious diseases 1983;5 Suppl 4():S670-7.
1983: E Whitnack; James B Dale; E H Beachey
Streptococcal defenses against host immune attack: the M protein-fibrinogen interaction.
Transactions of the Association of American Physicians 1983;96():197-202.
1982: David L Hasty; E H Beachey; W A Simpson; James B Dale
Hybridoma antibodies against protective and nonprotective antigenic determinants of a structurally defined polypeptide fragment of streptococcal M protein.
The Journal of experimental medicine 1982;155(4):1010-8.